Giorgio Treglia

Summary

Country: Italy

Publications

  1. doi Unusual increased metaiodobenzylguanidine uptake in liposarcoma
    Giorgio Treglia
    Nuclear Medicine Institute, Universita Cattolica del Sacro Cuore, Policlinico Gemelli, Rome, Italy
    Clin Nucl Med 33:627-9. 2008
  2. ncbi Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review
    G Treglia
    Institute of Nuclear Medicine, Department of Bioimages and Radiological Sciences, Catholic University of the Sacred Heart, Rome, Italy
    Sarcoidosis Vasc Diffuse Lung Dis 28:87-94. 2011
  3. pmc (123)I-MIBG Scintigraphy as a Powerful Tool to Plan an Implantable Cardioverter Defibrillator and to Assess Cardiac Resynchronization Therapy in Heart Failure Patients
    Antonella Stefanelli
    Department of Radiological Sciences, Institute of Nuclear Medicine, Universita Cattolica del Sacro Cuore, Largo Agostino Gemelli 8, 00168 Rome, Italy
    Int J Mol Imaging 2012:690468. 2012
  4. pmc The role of fluorine-18-fluorodeoxyglucose positron emission tomography in aggressive histological subtypes of thyroid cancer: an overview
    Giorgio Treglia
    Department of Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Via Ospedale 12, 6500 Bellinzona, Switzerland
    Int J Endocrinol 2013:856189. 2013
  5. pmc Fluorine-18-fluorodeoxyglucose positron emission tomography in assessing retroperitoneal fibrosis: a literature review
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Largo Gemelli, 00168 Rome, Italy
    Int J Mol Imaging 2012:484052. 2012
  6. ncbi The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review
    Giorgio Treglia
    Department of Nuclear Medicine and PET CT Center, Oncology Institute of Southern Switzerland, Via Ospedale 12, Bellinzona, 6500 Switzerland Electronic address
    Acad Radiol 21:675-84. 2014
  7. pmc F-FDG PET Imaging in the Evaluation of Treatment Response to New Chemotherapies beyond Imatinib for Patients with Gastrointestinal Stromal Tumors
    Antonella Stefanelli
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Largo Gemelli, 8, 00168 Rome, Italy
    ISRN Gastroenterol 2011:824892. 2011
  8. pmc Comparison between F-Fluorodeoxyglucose Positron Emission Tomography and Sentinel Lymph Node Biopsy for Regional Lymph Nodal Staging in Patients with Melanoma: A Review of the Literature
    Paoletta Mirk
    Department of Bioimaging and Radiological Sciences, Institute of Radiology, Catholic University of the Sacred Heart, 00168 Rome, Italy
    Radiol Res Pract 2011:912504. 2011
  9. pmc Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with neurofibromatosis type 1: a systematic review
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, 00168 Rome, Italy
    Radiol Res Pract 2012:431029. 2012
  10. doi Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the assessment of pleural abnormalities in cancer patients: a systematic review and a meta-analysis
    Giorgio Treglia
    Department of Nuclear Medicine and PET CT Center, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland Electronic address
    Lung Cancer 83:1-7. 2014

Detail Information

Publications78

  1. doi Unusual increased metaiodobenzylguanidine uptake in liposarcoma
    Giorgio Treglia
    Nuclear Medicine Institute, Universita Cattolica del Sacro Cuore, Policlinico Gemelli, Rome, Italy
    Clin Nucl Med 33:627-9. 2008
  2. ncbi Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review
    G Treglia
    Institute of Nuclear Medicine, Department of Bioimages and Radiological Sciences, Catholic University of the Sacred Heart, Rome, Italy
    Sarcoidosis Vasc Diffuse Lung Dis 28:87-94. 2011
    ..This study was designed to systematically review the emerging role of whole-body positron emission tomography (PET) with 18F-Fluorodeoxyglucose (FDG) in patients with sarcoidosis...
  3. pmc (123)I-MIBG Scintigraphy as a Powerful Tool to Plan an Implantable Cardioverter Defibrillator and to Assess Cardiac Resynchronization Therapy in Heart Failure Patients
    Antonella Stefanelli
    Department of Radiological Sciences, Institute of Nuclear Medicine, Universita Cattolica del Sacro Cuore, Largo Agostino Gemelli 8, 00168 Rome, Italy
    Int J Mol Imaging 2012:690468. 2012
    ..Furthermore, (123)I-MIBG scintigraphy seems to predict which patients will response to CRT with an improvement in left ventricular function...
  4. pmc The role of fluorine-18-fluorodeoxyglucose positron emission tomography in aggressive histological subtypes of thyroid cancer: an overview
    Giorgio Treglia
    Department of Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Via Ospedale 12, 6500 Bellinzona, Switzerland
    Int J Endocrinol 2013:856189. 2013
    ..However, DTC presenting as radioiodine refractory and FDG-PET positive should be considered aggressive tumours with poor prognosis...
  5. pmc Fluorine-18-fluorodeoxyglucose positron emission tomography in assessing retroperitoneal fibrosis: a literature review
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Largo Gemelli, 00168 Rome, Italy
    Int J Mol Imaging 2012:484052. 2012
    ..Moreover, further studies are needed to substantiate the role of FDG-PET and PET/CT in patients with RF...
  6. ncbi The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review
    Giorgio Treglia
    Department of Nuclear Medicine and PET CT Center, Oncology Institute of Southern Switzerland, Via Ospedale 12, Bellinzona, 6500 Switzerland Electronic address
    Acad Radiol 21:675-84. 2014
    ..To provide an updated evidence-based review of the literature on the role of fluorine-18-fluorodeoxyglucose positron emission tomography (FDG-PET) or PET/computed tomography (PET/CT) in patients with sarcoidosis...
  7. pmc F-FDG PET Imaging in the Evaluation of Treatment Response to New Chemotherapies beyond Imatinib for Patients with Gastrointestinal Stromal Tumors
    Antonella Stefanelli
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Largo Gemelli, 8, 00168 Rome, Italy
    ISRN Gastroenterol 2011:824892. 2011
    ..However, a dual modality PET-CT imaging is recommendable to achieve a better detection of all lesions...
  8. pmc Comparison between F-Fluorodeoxyglucose Positron Emission Tomography and Sentinel Lymph Node Biopsy for Regional Lymph Nodal Staging in Patients with Melanoma: A Review of the Literature
    Paoletta Mirk
    Department of Bioimaging and Radiological Sciences, Institute of Radiology, Catholic University of the Sacred Heart, 00168 Rome, Italy
    Radiol Res Pract 2011:912504. 2011
    ..Results and Conclusions. There is consensus in the literature that FDG-PET cannot replace SLNB for regional lymph nodal staging in patients with melanoma...
  9. pmc Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with neurofibromatosis type 1: a systematic review
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, 00168 Rome, Italy
    Radiol Res Pract 2012:431029. 2012
    ..Conclusions. FDG-PET and PET/CT are useful methods to identify malignant change in neurogenic tumors in NF1 and to discriminate malignant from benign neurogenic lesions...
  10. doi Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the assessment of pleural abnormalities in cancer patients: a systematic review and a meta-analysis
    Giorgio Treglia
    Department of Nuclear Medicine and PET CT Center, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland Electronic address
    Lung Cancer 83:1-7. 2014
    ....
  11. ncbi Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography for the diagnosis of osteomyelitis related to diabetic foot: a systematic review and a meta-analysis
    Giorgio Treglia
    Department of Nuclear Medicine and PET CT Center, Ente Ospedaliero Cantonale, Bellinzona, Switzerland Electronic address
    Foot (Edinb) 23:140-8. 2013
    ....
  12. ncbi Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis
    Giorgio Treglia
    Department of Nuclear Medicine and PET CT Center, Oncology Institute of Southern Switzerland, Via Ospedale, 12 6500 Bellinzona, Switzerland Electronic address
    Acad Radiol 21:11-20. 2014
    ....
  13. doi A rare case of primary thymic Hodgkin lymphoma in an elderly patient detected by 18F-FDG PET/CT
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Clin Nucl Med 38:e236-8. 2013
    ..On the basis of the PET/CT findings, the patient was referred to surgery with the clinical suspicious of a thymoma. Histological examination demonstrated the presence of a primary thymic Hodgkin lymphoma instead...
  14. doi Usefulness of (18)F-FDG PET/CT in disease extent and treatment response assessment in a patient with syphilitic aortitis
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Clin Nucl Med 38:e185-7. 2013
    ..This case highlights the usefulness of FDG PET/CT for the assessment of disease extent and treatment response in patients with syphilitic aortitis...
  15. doi Markedly increased 18F-FDG uptake in a nonfunctioning adrenal adenoma mimicking malignancy
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Clin Nucl Med 38:e333-5. 2013
    ....
  16. ncbi Nodular nongranulomatous vasculitis of the lung detected by 18F-FDG PET/CT
    Giorgio Treglia
    Institute of Nuclear Medicine and Department of Pathology, Catholic University of the Sacred Heart, Rome, Italy
    Clin Nucl Med 38:e148-51. 2013
    ..Histological examination demonstrated the presence of an obliterative vasculitis with interstitial pulmonary perivascular inflammation...
  17. doi Diagnostic performance of (99m)Tc-MIBI scan in predicting the malignancy of thyroid nodules: a meta-analysis
    Giorgio Treglia
    Department of Nuclear Medicine, Oncology Institute of Southern Switzerland, Via Ospedale 12, 6500, Bellinzona, Switzerland
    Endocrine 44:70-8. 2013
    ..Higher specificity can be reached when hypofunctioning thyroid nodules are considered...
  18. doi A rare case of ectopic adrenocorticotropic hormone syndrome caused by a metastatic neuroendocrine tumor of the pancreas detected by 68Ga-DOTANOC and 18F-FDG PET/CT
    Giorgio Treglia
    Institute of Nuclear Medicine, Department of Bioimaging and Radiological Sciences, Catholic University of the Sacred Heart, Rome, Italy
    Clin Nucl Med 38:e306-8. 2013
    ..Histology showed the presence of a mildly differentiated pancreatic NET. 68Ga-DOTANOC PET/CT may be a useful functional imaging method, complementary to 18F-FDG PET/CT, in detecting ACTH-secreting pancreatic NETs...
  19. doi A case of insulinoma detected by (68)Ga-DOTANOC PET/CT and missed by (18)F-dihydroxyphenylalanine PET/CT
    Giorgio Treglia
    Institute of Nuclear Medicine, Department of Bioimaging and Radiological Sciences, Catholic University of the Sacred Heart, Rome, Italy
    Clin Nucl Med 38:e267-70. 2013
    ..F-DOPA PET may fail in localizing insulin secreting tumors in adults; in these cases, the use of Ga-somatostatin analogs may lead to the correct diagnosis...
  20. ncbi Pharmacological interference with 123I-metaiodobenzylguanidine: a limitation to developing cardiac innervation imaging in clinical practice?
    A Stefanelli
    Institute of Nuclear Medicine, School of Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Eur Rev Med Pharmacol Sci 17:1326-33. 2013
    ..Thirty years after introduction of the method and over 15 years since the appearance of the first document on pharmacological interference with MIBG, an update on this issue has become necessary...
  21. doi The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview
    Giorgio Treglia
    Institute of Nuclear Medicine and PET CT Center, Catholic University of the Sacred Heart, Largo Gemelli, 8, 00168 Rome, Italy
    Eur Arch Otorhinolaryngol 270:1783-7. 2013
    ..FDG-PET report should suggest further evaluation when focal thyroid incidentalomas are described because these findings are associated with a significant risk of cancer...
  22. doi Pulmonary neuroendocrine tumor incidentally detected by (18)F-CH PET/CT
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Clin Nucl Med 38:e196-9. 2013
    ..Our case highlights that pulmonary NETs should be considered in the differential diagnosis of pulmonary lesions showing uptake of radiolabeled choline...
  23. doi Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography in patients with chronic inflammatory bowel disease: a systematic review and a meta-analysis
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of Sacred Heart, Rome, Italy
    J Crohns Colitis 7:345-54. 2013
    ....
  24. ncbi Emerging role of Fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a systematic review
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Rheumatol Int 33:549-55. 2013
    ..Moreover, further studies are needed to substantiate the role of FDG-PET and PET/CT in patients with RF...
  25. doi Usefulness of 18F-FDG PET/CT in an unusual case of solid-pseudopapillary pancreatic tumor in childhood with aggressive behavior
    Giorgio Treglia
    Institute of Nuclear Medicine, Department of Bioimaging and Radiological Sciences, Catholic University of the Sacred Heart, and Department of Oncohematology, Pediatric Hospital Bambino Gesu, Rome, Italy
    Clin Nucl Med 38:e35-7. 2013
    ..Based on PET/CT findings, the patient was referred to chemotherapy. In this unusual case of pediatric SPPT with aggressive behavior, ¹⁸F fluorodeoxyglucose PET/CT has been useful in staging the disease and in treatment planning...
  26. ncbi Clinical usefulness of myocardial innervation imaging using Iodine-123-meta-iodobenzylguanidine scintigraphy in evaluating the effectiveness of pharmacological treatments in patients with heart failure: an overview
    G Treglia
    Institute of Nuclear Medicine, School of Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Eur Rev Med Pharmacol Sci 17:56-68. 2013
    ....
  27. doi Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Largo Gemelli, 8, Rome 00168, Italy
    Clin Neurol Neurosurg 113:823-9. 2011
    ..This study was designed to review the diagnostic performance of iodine-123-metaiodobenzylguanidine (MIBG) scintigraphy in differential diagnosis between Parkinson's disease (PD) and multiple-system atrophy (MSA)...
  28. doi Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 fluorodeoxyglucose positron emission tomography: a meta-analysis
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of Sacred Heart, Largo Gemelli, 8, 00168, Rome, Italy
    Endocrine 42:535-45. 2012
    ..DR of FDG PET and PET/CT increases in patients with higher calcitonin and CEA values and lower CTDT and CEADT values, suggesting that these imaging methods could be very helpful in patients with more aggressive disease...
  29. ncbi Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 dihydroxyphenylalanine positron emission tomography: a meta-analysis
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Largo Gemelli, 8, 00168 Rome, Italy
    Acad Radiol 19:1290-9. 2012
    ....
  30. doi Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: a meta-analysis
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Largo Gemelli, 8, Rome 00168, Italy
    Pediatr Radiol 42:1372-9. 2012
    ..We performed a meta-analysis on published data on the diagnostic performance of fluorine-18 dihydroxyphenylalanine ((18)F-DOPA) positron emission tomography (PET) in diagnosing and localizing focal congenital hyperinsulinism (CHI)...
  31. doi Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Recent Results Cancer Res 194:385-93. 2013
    ..The information provided by the various PET tracers reflects different metabolic pathways, and may help to select the most appropriate treatment...
  32. ncbi Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis
    Giorgio Treglia
    Institute of Nuclear Medicine, Policlinico Gemellli, Catholic University of the Sacred Heart, Rome, Italy
    J Neuroimaging 22:111-7. 2012
    ....
  33. doi The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Ann Nucl Med 26:451-61. 2012
    ..Limited experience exists about the role of radiolabeled choline PET and PET/CT in patients with head and neck tumors, bladder cancer and gynecologic malignancies including breast cancer...
  34. ncbi Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Largo Gemelli, 8, 00168, Rome, Italy
    Endocrine 42:80-7. 2012
    ..Pooled sensitivity, pooled specificity and area under the ROC curve were calculated to measure the diagnostic accuracy of SMSR PET and PET/CT in NETs...
  35. doi 18F-Fluorodeoxyglucose positron emission tomography in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors: a systematic review
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Clin Imaging 36:167-75. 2012
    ..To systematically review the role of (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography (PET) in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors (GIST)...
  36. ncbi Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Eur J Nucl Med Mol Imaging 39:1144-53. 2012
    ..The aim of this study was to systematically review and conduct a meta-analysis of published data about the diagnostic performance of (18)F-dihydroxyphenylalanine (DOPA) positron emission tomography (PET) in patients with paraganglioma (PG)...
  37. ncbi The role of nuclear medicine in the diagnosis of spondylodiscitis
    G Treglia
    Institute of Nuclear Medicine, School of Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Eur Rev Med Pharmacol Sci 16:20-5. 2012
    ..The diagnosis of spondylodiscitis can be difficult, because the patients history, subjective symptoms and physical findings are often inconclusive, particularly in the early stages...
  38. doi Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma
    Giorgio Treglia
    Institute of Nuclear Medicine, Policlinico A Gemelli, Catholic University of the Sacred Heart, Rome, Italy
    Eur J Nucl Med Mol Imaging 39:569-80. 2012
    ..To retrospectively evaluate and compare (18)F-FDG, (18)F-DOPA and (68)Ga-somatostatin analogues for PET/CT in patients with residual/recurrent medullary thyroid carcinoma (MTC) suspected on the basis of elevated serum calcitonin levels...
  39. doi Clinical significance of incidental focal colorectal (18)F-fluorodeoxyglucose uptake: our experience and a review of the literature
    G Treglia
    Institute of Nuclear Medicine, Universita Cattolica del Sacro Cuore, Rome, Italy
    Colorectal Dis 14:174-80. 2012
    ....
  40. doi Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases
    Giorgio Treglia
    Nuclear Medicine Unit, Maggiore Hospital Bologna, Largo Nigrisoli 2, 40133, Bologna, Italy
    Neurol Sci 31:417-22. 2010
    ..We also reported the results of clinical investigations about the correlation between characteristics of Parkinson's disease and myocardial MIBG uptake...
  41. doi Is there a role for fluorine 18 fluorodeoxyglucose-positron emission tomography and positron emission tomography/computed tomography in evaluating patients with mycobacteriosis? A systematic review
    Giorgio Treglia
    Nuclear Medicine Unit, Department of Bioimaging and Radiological Sciences, Catholic University of Sacred Heart, Rome, Italy
    J Comput Assist Tomogr 35:387-93. 2011
    ..This study was designed to review the emerging role of fluorine 18 fluorodeoxyglucose (¹⁸F-FDG)-positron emission tomography (PET) CT/computed tomography (PET/CT) in patients with mycobacteriosis...
  42. ncbi Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis
    Giorgio Treglia
    Department of Bioimaging and Radiological Sciences, Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Skeletal Radiol 41:249-56. 2012
    ....
  43. doi MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis
    Giorgio Treglia
    Institute of Nuclear Medicine, Policlinico Gemelli, Catholic University of the Sacred Heart, Rome, Italy
    Clin Auton Res 22:43-55. 2012
    ....
  44. doi Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review
    Giorgio Treglia
    Institute of Nuclear Medicine, Positron Emission Tomography Centre, Catholic University of the Sacred Heart, Largo Gemelli 8, Rome, 00168, Italy
    Clin Rheumatol 30:1265-75. 2011
    ....
  45. doi Usefulness of fluorine-18 fluorodeoxyglucose PET/computed tomography in diagnosis of aortitis and treatment response evaluation in a patient with aortic prosthesis
    Giorgio Treglia
    Department of Bioimaging and Radiological Sciences, Institute of Nuclear Medicine, Italy
    J Cardiovasc Med (Hagerstown) 12:814-6. 2011
    ..We also describe the correlation between decrease of FDG uptake in the vascular prosthesis after treatment and clinical improvement with normalization of the serological levels of inflammatory markers...
  46. ncbi The role of nuclear medicine in the management of thymomas
    Giorgio Treglia
    Istituto di Medicina Nucleare, Policlinico Universitario A Gemelli, Universita Cattolica del Sacro Cuore, Roma
    Ann Ital Chir 78:371-4. 2007
    ..To evaluate the role of nuclear medicine techniques in the management of patients with thymoma...
  47. doi Costal brown tumor detected by dual-phase parathyroid imaging and SPECT-CT in primary hyperparathyroidism
    Giorgio Treglia
    Institute of Nuclear Medicine, Universita Cattolica del Sacro Cuore, Rome, Italy
    Clin Nucl Med 33:193-5. 2008
  48. doi Thyroglobulin levels and thyroglobulin doubling time independently predict a positive 18F-FDG PET/CT scan in patients with biochemical recurrence of differentiated thyroid carcinoma
    Luca Giovanella
    Department of Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
    Eur J Nucl Med Mol Imaging 40:874-80. 2013
    ..To assess the relationship between serum thyroglobulin (Tg) levels, Tg doubling time (Tg-DT) and the diagnostic performance of (18)F-FDG PET/CT in detecting recurrences of (131)I-negative differentiated thyroid carcinoma (DTC)...
  49. pmc ¹⁸F-fluoro-deoxy-glucose focal uptake in very small pulmonary nodules: fact or artifact? Case reports
    Maria Lucia Calcagni
    Institute of Nuclear Medicine, Universita Cattolica del Sacro Cuore, Largo A, Gemelli, 8, 00168 Rome, Italy
    World J Surg Oncol 10:71. 2012
    ..The diagnostic performance of 18 F-FDG is similar for nodules measuring at least 1 cm and for larger masses, but few data exist for nodules smaller than 1 cm...
  50. doi Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma
    Vittoria Rufini
    Institute of Nuclear Medicine, Catholic University of Sacred Heart, Rome, Italy
    Nucl Med Commun 32:575-82. 2011
    ....
  51. doi Role of PET/CT in the functional imaging of endocrine pancreatic tumors
    Vittoria Rufini
    Department of Bioimaging and Radiological Sciences, Institute of Nuclear Medicine, Agostino Gemelli Hospital, Universita Cattolica del Sacro Cuore, Roma, Italy
    Abdom Imaging 37:1004-20. 2012
    ..In addition, (68)Ga-DOTA-peptides play a distinctive role in planning peptide receptor radionuclide therapy...
  52. ncbi Nuclear medicine procedures in the diagnosis and therapy of medullary thyroid carcinoma
    Vittoria Rufini
    Institute of Nuclear Medicine, Universita Cattolica del Sacro Cuore, Rome, Italy
    Biomed Pharmacother 62:139-46. 2008
    ..Interesting perspectives for MTC imaging are offered by PET radiopharmaceuticals...
  53. ncbi Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography imaging in uterine sarcomas: systematic review and meta-analysis of the literature
    Ramin Sadeghi
    Nuclear Medicine Research Center, Women s Health Research Center, Mashhad University of Medical Sciences Faculty of Medicine, Ghaem Hospital, Mashhad, Iran and Department of Nuclear Medicine and PET CT Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
    Int J Gynecol Cancer 23:1349-56. 2013
    ....
  54. ncbi Multifocal extra-adrenal paraganglioma evaluated with different PET tracers: comparison between 18F-FDG, 18F-DOPA and 68Ga DOTANOC PET/CT
    Giorgio Treglia
    From the Department of Bioimaging and Radiological Sciences, Institute of Nuclear Medicine, Catholic University of the Sacred Heart and Department of Thoracic Surgery, Carlo Forlanini Hospital, Rome, Italy
    Clin Nucl Med 38:e458-62. 2013
    ..68Ga-DOTANOC PET/CT detected 2 additional lesions compared to the other PET/CT methods. In our case, somatostatin receptor PET/CT with 68Ga-DOTANOC correctly assessed the extent of the disease in a patient with multifocal paraganglioma...
  55. ncbi The evolution in the use of MIBG scintigraphy in pheochromocytomas and paragangliomas
    Vittoria Rufini
    Institute of Nuclear Medicine, Universita Cattolica del Sacro Cuore, Rome, Italy
    Hormones (Athens) 12:58-68. 2013
    ....
  56. ncbi Malignant pleural mesothelioma: utility of 18 F-FDG PET
    Maria Grazia Spitilli
    Istituto di Medicina Nucleare, Universita Cattolica del Sacro Cuore, Policlinico A Gemelli, Roma
    Ann Ital Chir 78:393-6. 2007
    ....
  57. ncbi PET and PET/CT imaging in thyroid and adrenal diseases: an update
    Giorgio Treglia
    Department of Nuclear Medicine and PET CT Center, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
    Hormones (Athens) 12:327-33. 2013
    ....
  58. ncbi Noninvasive adrenal imaging in hyperaldosteronism: is it accurate for correctly identifying patients who should be selected for surgery?
    Celestino Pio Lombardi
    Divisione di Endocrinochirurgia, Istituto di Clinica Chirurgica, Universita Cattolica del Sacro Cuore, Largo A Gemelli, 8, 00168, Rome, Italy
    Langenbecks Arch Surg 392:623-8. 2007
    ..We evaluated if non-invasive preoperative imaging studies are able to reliably differentiate these causes of hyperaldosteronism...
  59. doi [¹⁸F]FDG-PET/CT in patients affected by retroperitoneal fibrosis: a bicentric experience
    Francesco Bertagna
    Department of Nuclear Medicine, University of Brescia and Spedali Civili di Brescia, P le Spedali Civili, 1, 25123 Brescia, Italy
    Jpn J Radiol 30:415-21. 2012
    ..The aim of our study was to assess the feasibility and usefulness of 2-[(18)F]-fluoro-2-deoxy-D: -glucose positron emission tomography computed tomography ([(18)F]FDG-PET/CT) in patients affected by retroperitoneal fibrosis...
  60. doi Is fluorine-18-fluorodeoxyglucose positron emission tomography useful in monitoring the response to treatment in patients with multiple myeloma?
    Carmelo Caldarella
    Department of Bioimaging and Radiological Sciences, Institute of Nuclear Medicine, Universita Cattolica del Sacro Cuore, Largo Gemelli, 8, 00168, Rome, Italy
    Int J Hematol 96:685-91. 2012
    ..These articles were retrieved in full-text version and analyzed. Based on these findings from the literature, FDG-PET or PET/CT appear to be useful in the assessment of treatment response in patients with MM...
  61. ncbi A rare case of solitary fibrous tumor of the adrenal gland detected by (18)F-FDG PET/CT
    Giorgio Treglia
    From the Department of Nuclear Medicine, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland Division of Endocrine and Metabolic Surgery Institute of Pathology and Institute of Nuclear Medicine, Universita Cattolica del Sacro Cuore, Rome, Italy
    Clin Nucl Med 39:475-7. 2014
    ..This case highlights that benign solitary fibrous tumor should be considered as possible false-positive F-FDG PET/CT finding for malignancy in evaluating adrenal incidentalomas. ..
  62. doi Thyroid lobe ablation with iodine- ¹³¹I in patients with differentiated thyroid carcinoma: a randomized comparison between 1.1 and 3.7 GBq activities
    Luca Giovanella
    Department of Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
    Nucl Med Commun 34:767-70. 2013
    ..The present study was undertaken to evaluate the ablation rate after administration of 1.1 or 3.7 GBq of iodine- (¹³¹I) to patients with low-risk differentiated thyroid carcinoma (DTC) primarily treated by lobectomy...
  63. pmc The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma
    Natale Quartuccio
    Department of Radiological Sciences, Nuclear Medicine Unit, University of Messina, Messina, Italy
    Radiol Oncol 47:97-102. 2013
    ..The objective of this study is to systematically review the role of positron emission tomography (PET) and PET/computed tomography (PET/CT) with Fluorine-18-Fluorodeoxyglucose (FDG) in patients with osteosarcoma (OS)...
  64. ncbi A Rare Case of Synchronous Bilateral Pulmonary Neuroendocrine Tumor Detected by 68Ga-DOTANOC PET/CT
    Silvia Taralli
    From the Department of Bioimaging and Radiologial Sciences, Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Rome, Italy and Units of Pathology and Thoracic Surgery, San Camillo Forlanini Hospital, Rome, Italy
    Clin Nucl Med 37:e91-4. 2012
    ..This case reports a rare occurrence of synchronous pulmonary carcinoid, highlighting the role of different PET tracers for metabolic characterization of pulmonary nodules...
  65. pmc A comparison between ¹⁸F-FDG PET/CT imaging and biological and radiological findings in restaging of hepatoblastoma patients
    Angelina Cistaro
    Positron Emission Tomography Centre, IRMET S p A, Euromedic Inc, 10136 Turin, Italy Co ordinator of PET Pediatric AIMN InterGroup, 10136 Turin, Italy Associate researcher of Institute of Cognitive Sciences and Technologies, National Research Council, 00185 Rome, Italy
    Biomed Res Int 2013:709037. 2013
    ..In this study we retrospectively evaluated if ¹⁸F-FDG-PET/CT provided incremental diagnostic information over CI in a group of hepatoblastoma patients performing restaging...
  66. ncbi A thyroid incidentaloma detected by 18F-choline PET/CT
    Giorgio Treglia
    From the Institute of Nuclear Medicine, Institute of Radiology, Department of Surgery, Division of Endocrine Surgery, Catholic University of the Sacred Heart, Rome and Department of Nuclear Medicine, University of Brescia, Brescia, Italy
    Clin Nucl Med 39:e267-9. 2014
    ..Based on PET/CT findings, the patient underwent a ultrasonography guided fine-needle aspiration biopsy which demonstrated the presence of a benign thyroid nodule...
  67. doi Diagnostic performance of positron emission tomography using ¹¹C-methionine in patients with suspected parathyroid adenoma: a meta-analysis
    Carmelo Caldarella
    Institute of Nuclear Medicine, Department of Bioimaging and Radiological Sciences, Universita Cattolica del Sacro Cuore, Largo Agostino Gemelli 8, 00168, Rome, Italy
    Endocrine 43:78-83. 2013
    ..Thus, this imaging method could be helpful in patients with diagnosis of primary hyperparathyroidism when conventional imaging techniques are negative or inconclusive in localizing parathyroid adenoma...
  68. doi Diagnostic performance of planar scintigraphy using ⁹⁹mTc-MIBI in patients with secondary hyperparathyroidism: a meta-analysis
    Carmelo Caldarella
    Department of Bioimaging and Radiological Sciences, Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168 Rome, Italy
    Ann Nucl Med 26:794-803. 2012
    ..The aim of our study is to meta-analyze the published data about the diagnostic performance of (99m)Tc-MIBI parathyroid scintigraphy in patients with SHPT...
  69. doi Serum cytokeratin 19 fragments: a dedifferentiation marker in advanced thyroid cancer
    Luca Giovanella
    Department of Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Via Ospedale 12, CH 6500 Bellinzona, Switzerland
    Eur J Endocrinol 167:793-7. 2012
    ..1) expressions in patients with advanced thyroid carcinoma and to explore the relationship between serum Cyfra 21.1 and the degree of radioiodine ((131)I) avidity of thyroid carcinoma cells...
  70. pmc PET Imaging in Recurrent Medullary Thyroid Carcinoma
    Giorgio Treglia
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, 00168 Rome, Italy
    Int J Mol Imaging 2012:324686. 2012
    ..FDOPA seems to be the most useful PET tracer in detecting recurrent MTC based on rising levels of tumor markers. FDG may complement FDOPA in patients with more aggressive MTC...
  71. doi Usefulness of F-18 FDG PET/CT in the follow-up of POEMS syndrome after autologous peripheral blood stem cell transplantation
    Antonella Stefanelli
    Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Clin Nucl Med 37:181-3. 2012
    ..After autologous peripheral blood stem cell transplantation, F-18 FDG PET/CT may play a pivotal role in detecting new bone lesions in patients with POEMS syndrome, which may be treated by a focalized radiotherapy and/or systemic therapy...
  72. doi Incidental 11C-choline PET/CT brain uptake due to meningioma in a patient studied for prostate cancer: correlation with MRI and imaging fusion
    Francesco Bertagna
    From the Department of Nuclear Medicine and Neuroradiology, University of Brescia and Spedali Civili Brescia, Brescia and Department of Nuclear Medicine, Catholic University of Sacred Heart, Rome, Italy
    Clin Nucl Med 38:e435-7. 2013
    ..The study was negative for secondary lesions but revealed an incidental pathologic focal brain uptake. A subsequent magnetic resonance examination confirmed the presence of a brain lesion typical for meningioma...
  73. ncbi The evolution in the use of MIBG scintigraphy in pheochromocytomas and paragangliomas
    Vittoria Rufini
    Institute of Nuclear Medicine, Universita Cattolica del Sacro Cuore, Rome, Italy
    Hormones (Athens) 12:58-68. 2013
    ....
  74. ncbi Atypical Presentation of Plasma Cell Leukemia Secondary to Multiple Myeloma Detected by F-18 FDG PET/CT
    Fabrizio Cocciolillo
    From the Department of Bioimaging and Radiological Sciences, Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Clin Nucl Med 36:e220-3. 2011
    ..F-18 FDG PET/CT showed areas of increased radiopharmaceutical uptake in some muscles of the right leg and right thigh, corresponding to muscle localization of PCL, therefore allowing adequate treatment planning...
  75. pmc The Role of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Assessing the Response to Neoadjuvant Treatment in Patients with Osteosarcoma
    Carmelo Caldarella
    Department of Bioimaging and Radiological Sciences, Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Largo Gemelli 8, 00168 Rome, Italy
    Int J Mol Imaging 2012:870301. 2012
    ..However, false positive findings due to inflammation in sites of tumoral response should be considered...
  76. ncbi Combined diagnostic imaging in a patient with Forestier disease and dysphagia
    Gaetano Squadrito
    Istituto di Medicina Nucleare, Universita Cattolica del S Cuore, Policlnico A Gemelli, Roma, Italy
    Rays 30:251-5. 2005
    ..CT of the cervical vertebral column documented anterior diffuse vertebral hyperostosis of C3-C6: this finding was suggestive of Forestier disease...